Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments
- PMID: 20668304
Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments
Abstract
Indole-3-carbinol (I3C) when given orally is converted to diindolylmethane (DIM) and other oligomers catalyzed by stomach acid. This suggests that DIM is the predominant active agent and that I3C is a precursor, 'pro-drug' in vivo. However, in cell culture studies carried out in neutral solutions, I3C has been considered fully active.
Materials and methods: The stability of I3C in cell culture media was studied.
Results: In the 8 different cell culture media tested, greater than 50% dimerization of I3C into DIM occurred in 24 hours. At 48 hour, greater than 60% conversion was found. When neutral synthetic cerebrospinal fluid (CSF) or peritoneal fluid (PF) was studied, a large peak, tentitively identified as I3C's linear trimer (LTR) conversion product by mass spectra, and two smaller peaks, were seen. When CSF or PF was diluted 1:1 with media, the formation of these additional peaks was diminished.
Conclusion: Because of the greater biologic potency of DIM when studied in parallel with I3C in vitro, this extent of dimerization shows that DIM rather than I3C is the active agent in cell culture studies.
Similar articles
-
Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer.In Vivo. 2008 Jul-Aug;22(4):441-5. In Vivo. 2008. PMID: 18712169 Review.
-
Broccoli-derived phytochemicals indole-3-carbinol and 3,3'-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: comparison with other cancer preventive phytochemicals.Mol Carcinog. 2012 Mar;51(3):244-56. doi: 10.1002/mc.20774. Epub 2011 Apr 22. Mol Carcinog. 2012. PMID: 21520295
-
Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane.Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2477-81. doi: 10.1158/1055-9965.EPI-06-0396. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17164373 Clinical Trial.
-
Estrogen receptor alpha as a target for indole-3-carbinol.J Nutr Biochem. 2006 Oct;17(10):659-64. doi: 10.1016/j.jnutbio.2005.10.012. Epub 2005 Nov 28. J Nutr Biochem. 2006. PMID: 16488130
-
Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3'-diindolylmethane in sprague-dawley rats.Toxicol Sci. 2003 Jul;74(1):10-21. doi: 10.1093/toxsci/kfg103. Epub 2003 May 2. Toxicol Sci. 2003. PMID: 12730619 Review.
Cited by
-
Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans.Nat Immunol. 2018 Jun;19(6):571-582. doi: 10.1038/s41590-018-0107-1. Epub 2018 May 14. Nat Immunol. 2018. PMID: 29760532 Free PMC article.
-
Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies.Nutr Rev. 2016 Jul;74(7):432-43. doi: 10.1093/nutrit/nuw010. Epub 2016 May 31. Nutr Rev. 2016. PMID: 27261275 Free PMC article. Review.
-
Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients.Am J Transl Res. 2016 Jan 15;8(1):166-76. eCollection 2016. Am J Transl Res. 2016. PMID: 27069550 Free PMC article.
-
3,3'-Diindolylmethane (DIM): A Molecular Scaffold for Inhibition of WWP1 and WWP2, Members of the NEDD4 Family HECT E3 Ligases.ACS Omega. 2025 Feb 10;10(6):5963-5972. doi: 10.1021/acsomega.4c09944. eCollection 2025 Feb 18. ACS Omega. 2025. PMID: 39989805 Free PMC article.
-
Enhanced inhibition of lung adenocarcinoma by combinatorial treatment with indole-3-carbinol and silibinin in A/J mice.Carcinogenesis. 2011 Apr;32(4):561-7. doi: 10.1093/carcin/bgr010. Epub 2011 Jan 27. Carcinogenesis. 2011. PMID: 21273642 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources